Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Medical Research Foundation, University Of Kentucky Research FoundationfiledCriticalOklahoma Medical Research Foundation
Priority to YU42395ApriorityCriticalpatent/YU49496B/en
Publication of YU42395ApublicationCriticalpatent/YU42395A/en
Publication of YU49496BpublicationCriticalpatent/YU49496B/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicinal Preparation
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Opisani su 2,3-disulfonil tercijarni butil nitron i njegove farmaceutski prihvatljive soli. Soli mogu sadržati farmaceutski prihvatljiv jednovalentni anjon. Farmaceutski preparat koji sadrži 2,3-disulfonil alfafenil tercijarni butil nitron i njegove farmaceutski prihvatljive soli zajedno sa farmaceutski prihvatljivim nosačem za parenteralne injekcije ili farmaceutski prihvatljivom nosaču za oralno davanje.2,3-Disulfonyl tertiary butyl nitron and its pharmaceutically acceptable salts are described. The salts may contain a pharmaceutically acceptable monovalent anion. A pharmaceutical composition comprising 2,3-disulfonyl alfaphenyl tertiary butyl nitron and its pharmaceutically acceptable salts together with a pharmaceutically acceptable carrier for parenteral injection or a pharmaceutically acceptable carrier for oral administration.
YU42395A1995-06-211995-06-212,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals
YU49496B
(en)
Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
USE OF 5'-DEOXI-5'-METHYL-THIOADENOSINE, S-ADENOSYLMETIONINE AND ITS SALTS FOR THE PREPARATION OF REDUCING PHARMACEUTICAL COMPOSITIONS OF SEBORRHEA.